VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
IBEXIBEX Limited
$30.08$405M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksIBEXFinancials

IBEX Limited (IBEX) Financials

10Y historyFree accessUpdated daily

Revenue growth has accelerated to 16.8% as of 2026Q3, though gross margins remain sensitive to operational shifts, having compressed from a 31.8% peak in 2025Q3 to 26.1% in 2026Q2.

IBEX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMJun'25Jun'24Jun'23Jun'22Jun'21Jun'20Jun'19Jun'18Jun'17Jun'16
Sales/Revenue626.95M558.27M508.57M523.12M492.85M443.39M405.13M368.38M342.2M334.03M323.02M
Revenue Growth %17.04%9.77%-2.78%6.14%11.16%9.44%9.98%7.65%2.44%3.41%-
Cost of Goods Sold328.83M385.69M356.54M374.99M373.97M335.25M276.25M254.59M252.93M276.19M260.59M
COGS % of Revenue-69.09%70.11%71.68%75.88%75.61%68.19%69.11%73.91%82.68%80.67%
Gross Profit133.71M172.58M152.03M148.13M118.88M108.14M128.88M113.79M89.28M57.84M62.43M
Gross Margin %21.33%30.91%29.89%28.32%24.12%24.39%31.81%30.89%26.09%17.32%19.33%
Gross Profit Growth %-13.52%2.64%24.6%9.93%-16.09%13.26%27.46%54.35%-7.35%-
Operating Expenses240.71M125.97M112.6M107.65M98.25M91.09M109.37M361.34M363.3M335.07M309.51M
OpEx % of Revenue-22.56%22.14%20.58%19.94%20.54%27%98.09%106.17%100.31%95.82%
Selling, General & Admin111.3M108.74M93.14M88.66M80.15M0350.42M321.72M332.93M306.12M281.72M
SG&A % of Revenue-19.48%18.31%16.95%16.26%-86.5%87.33%97.29%91.64%87.21%
Research & Development00000000000
R&D % of Revenue-----------
Other Operating Expenses3M17.23M19.46M18.98M18.1M91.09M-241.06M39.61M30.37M28.96M27.8M
Operating Income57.4M46.61M39.43M40.48M20.63M17.05M19.51M6.8M-17.78M-2.33M8.56M
Operating Margin %9.16%8.35%7.75%7.74%4.18%3.84%4.82%1.85%-5.19%-0.7%2.65%
Operating Income Growth %-18.21%-2.59%96.26%21%-12.65%186.75%138.28%-664.6%-127.15%-
EBITDA75.95M63.84M58.89M59.46M38.73M31.16M43.98M27.7M-5.59M11.51M21.22M
EBITDA Margin %12.11%11.44%11.58%11.37%7.86%7.03%10.86%7.52%-1.64%3.44%6.57%
EBITDA Growth %17.19%8.41%-0.96%53.55%24.27%-29.15%58.79%595.08%-148.62%-45.77%-
D&A (Non-Cash Add-back)18.55M17.23M19.46M18.98M18.1M14.12M24.47M20.89M12.18M13.83M12.65M
EBIT41.37M47.57M41.5M41.12M20.67M17.05M19M6.8M-18.91M-3.44M7.1M
Net Interest Income-795K-679K1.56M-152K-1.25M-9.03M-9.43M-7.71M-3.09M-6.39M-5.13M
Interest Income180K955K2.07M640K43K007.25M000
Interest Expense664K1.63M514K792K1.29M9.03M9.43M7.25M1.96M5.28M3.67M
Other Income/Expense-982K-679K1.56M-152K-1.25M-1.89M-9.43M-7.71M-3.09M-6.39M-5.13M
Pretax Income56.42M45.93M40.99M40.33M19.38M15.15M10.09M-904K-20.87M-8.72M3.43M
Pretax Margin %9%8.23%8.06%7.71%3.93%3.42%2.49%-0.25%-6.1%-2.61%1.06%
Income Tax3.95M9.07M7.33M8.74M-2.08M2.06M2.31M3.62M-108K295K1.86M
Effective Tax Rate %7.01%19.74%17.89%21.68%-10.72%13.62%22.95%-399.89%0.52%-3.38%54.22%
Net Income47.18M36.86M33.66M31.58M21.46M13.09M7.77M-4.52M-15.88M-9.01M1.57M
Net Margin %7.53%6.6%6.62%6.04%4.35%2.95%1.92%-1.23%-4.64%-2.7%0.49%
Net Income Growth %27.13%9.54%6.56%47.19%63.92%68.46%271.94%71.54%-76.2%-673.71%-
Net Income (Continuing)47.18M36.86M33.66M31.58M21.46M13.09M7.77M-4.52M-20.76M-9.01M1.57M
Discontinued Operations000000015.48M4.88M00
Minority Interest0000000020M20M3.64M
EPS (Diluted)3.152.361.841.671.150.150.44-0.26-0.90-0.510.09
EPS Growth %39.74%28.26%10.18%45.22%666.67%-65.91%269.23%71.11%-76.47%-674.32%-
EPS (Basic)-2.511.901.741.180.160.44-0.26-0.90-0.510.09
Diluted Shares Outstanding14.99M15.72M18.25M18.89M18.72M18.38M17.69M17.69M17.69M17.69M17.69M
Basic Shares Outstanding13.45M14.68M17.7M18.2M18.23M17.65M17.69M17.69M17.69M17.69M17.69M
Dividend Payout Ratio----------417.76%

Key Metrics

Growth RegimeAccelerating
ProfitabilityModerate
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Client concentration and attrition

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Revenue Growth Momentum Accelerates Significantly

According to the latest quarterly financial data, IBEX has successfully accelerated its top-line growth to 16.8% year-over-year as of 2026Q3, marking a distinct recovery from the negative growth rates observed in 2024, which suggests that the company's strategic focus on high-growth verticals is gaining meaningful traction.

The consistent quarterly revenue expansion from $124.5M in 2024Q4 to $164.4M in 2026Q3 indicates that the company is effectively capturing market share within its core CX and digital segments. Investors should monitor whether this acceleration is sustainable or if it remains heavily dependent on a narrow set of high-growth tech clients that may be prone to sudden budget contractions.

Structural Margin Volatility Remains Apparent

As reported in recent income statements, IBEX's gross margin has exhibited notable fluctuations, peaking at 31.8% in 2025Q3 before compressing to 26.1% in 2026Q2, which highlights the inherent sensitivity of the company's labor-intensive delivery model to wage inflation and shifting utilization rates across its global centers.

The inability to maintain a consistent gross margin above the 30% threshold suggests that the company faces ongoing challenges in balancing competitive pricing with rising personnel costs. This volatility warrants further investigation into whether the firm possesses sufficient pricing power to pass through inflationary pressures to its client base without sacrificing volume.

Operating Leverage Scaling Amidst Expansion

Based on the provided financial figures, IBEX has demonstrated an ability to scale its operating income to $16.2M in 2026Q3, suggesting that management is maintaining disciplined control over SG&A expenses even as the company aggressively pursues top-line growth across its diverse service pillars.

The operating margin of 9.8% in the most recent quarter reflects a lean corporate structure that appears to be benefiting from economies of scale. However, the reliance on variable labor costs means that any future decline in seat utilization could rapidly erode these gains, necessitating a close watch on operational efficiency metrics.

Earnings Quality Influenced by SBC

Analysis of the income statement reveals that IBEX's net income, which reached $13.3M in 2026Q3, is periodically impacted by stock-based compensation charges, such as the $2.5M expense recorded in 2026Q1, which complicates the assessment of true underlying profitability and shareholder dilution risks over the long term.

While the company has shown strong EPS growth, the variability in non-cash charges suggests that investors should focus on normalized earnings to gauge the true health of the business. The absence of R&D expenses in the provided data also raises questions regarding how the company accounts for the development of its proprietary CX software platforms.

IBEX — Frequently Asked Questions

Quick answers to the most common questions about buying IBEX stock.

What was IBEX Limited's (IBEX) revenue in 2025?

For fiscal year 2025, IBEX Limited (IBEX) reported total revenue of $558.3M. This represents a 72.8% increase compared to $323.0M in 2016.

Is IBEX Limited (IBEX) profitable?

IBEX Limited (IBEX) is profitable, generating $36.9M in net income for the fiscal year ending 2025 with a net profit margin of 6.6%.

What is IBEX Limited's operating profit margin?

IBEX Limited (IBEX) reported an operating income of $46.6M, resulting in an operating profit margin of 8.3%. This margin reflects the operational efficiency of the business before interest and taxes.

What is IBEX Limited's gross profit and gross margin?

IBEX Limited (IBEX) generated $172.6M in gross profit for the year, representing a gross profit margin of 30.9%. This demonstrates the company's core pricing power and production efficiency.